Long-term disease course in a patient with severe neonatal IPEX syndrome

Clinics and Research in Hepatology and Gastroenterology

Volumn 39, Issue 4, 2015, Pages e43-e47

  Duclaux Loras, Rémi ^a,b,c   Collardeau Frachon, Sophie ^d   Nancey, Stephane ^c,d   Fabien, Nicole ^d,e   Kaiserlian, Dominique ^d   Lachaux, Alain ^a,b,c  

^a University Hospitals of Lyon   (France)

^b HOSPICES CIVILS DE LYON   (France)

^c CENTRE INTERNATIONAL DE RECHERCHE EN INFECTIOLOGIE   (France)

^d UNIVERSITÉ LYON 1   (France)

^e CENTRE HOSPITALIER LYON SUD   (France)

Author keywords

[No Author keywords available]

Indexed keywords

AMPHOTERICIN B DEOXYCHOLATE; ANTIBIOTIC AGENT; AUTOANTIBODY; AZATHIOPRINE; CORTICOSTEROID; COTRIMOXAZOLE; CYCLOSPORIN; DIPHTHERIA PERTUSSIS TETANUS VACCINE; IMMUNOGLOBULIN A; IMMUNOGLOBULIN E; IMMUNOGLOBULIN G; IMMUNOGLOBULIN M; IMMUNOSUPPRESSIVE AGENT; MEASLES MUMPS RUBELLA VACCINE; MYCOPHENOLATE MOFETIL; PREDNISOLONE; RAPAMYCIN; SODIUM; TRANSCRIPTION FACTOR FOXP3; WATER; GLUCOCORTICOID; MYCOPHENOLIC ACID;

ACUTE OTITIS MEDIA; ANTIBIOTIC THERAPY; ARTHRALGIA; ARTICLE; ASTHENIA; BCG VACCINATION; CASE REPORT; CODON; DIARRHEA; DISEASE COURSE; DRUG WITHDRAWAL; ECZEMA; EXON; GENE; HISTOPATHOLOGY; HUMAN; HUMAN CELL; HUMAN TISSUE; HYPERTRICHOSIS; HYPERTROPHY; IMMUNOSUPPRESSIVE TREATMENT; INTENSIVE CARE UNIT; IPEX SYNDROME; LIVER BIOPSY; LIVER FUNCTION TEST; MALE; NEWBORN; OSTEOPENIA; OUTCOME ASSESSMENT; RASH; SEPTICEMIA; ANALOGS AND DERIVATIVES; BLOOD; COMBINATION DRUG THERAPY; DIABETES MELLITUS, TYPE 1; FOLLOW UP; GASTROINTESTINAL ENDOSCOPY; GENETIC DISEASES, X-LINKED; GLOMERULUS FILTRATION RATE; IMMUNE SYSTEM DISEASES; LIVER CIRRHOSIS; PATHOLOGY; YOUNG ADULT;

CYCLOSPORINE; DIABETES MELLITUS, TYPE 1; DIARRHEA; DRUG THERAPY, COMBINATION; ENDOSCOPY, GASTROINTESTINAL; FOLLOW-UP STUDIES; GENETIC DISEASES, X-LINKED; GLOMERULAR FILTRATION RATE; GLUCOCORTICOIDS; HUMANS; IMMUNE SYSTEM DISEASES; IMMUNOGLOBULIN E; IMMUNOSUPPRESSIVE AGENTS; INFANT, NEWBORN; LIVER CIRRHOSIS; MALE; MYCOPHENOLIC ACID; PREDNISOLONE; YOUNG ADULT;

EID: 84940899524     PISSN: 22107401     EISSN: 2210741X     Source Type: Journal    
DOI: 10.1016/j.clinre.2015.03.006     Document Type: Article

References (14)

1. Bennett C.L., Christie J., Ramsdell F., Brunkow M.E., Ferguson P.J., Whitesell L., et al. The immune dysregulation, polyendocrinopathy, enteropathy, X-linked syndrome (IPEX) is caused by mutations of FOXP3. Nat Genet 2001, 27:20-21.
2. Burroughs L.M., Torgerson T.R., Storb R., Carpenter P.A., Rawlings D.J., Sanders J., et al. Stable hematopoietic cell engraftment after low-intensity non-myeloablative conditioning in patients with immune dysregulation, polyendocrinopathy, enteropathy, X-linked syndrome. J Allergy Clin Immunol 2010, 126:1000-1005.
3. Barzaghi F., Passerini L., Bacchetta R. Immune dysregulation, polyendocrinopathy, enteropathy, X-linked syndrome: a paradigm of immunodeficiency with autoimmunity. Front Immunol 2012, 3:211.
4. Lachaux A., Bouvier R., Cozzani E., Loras-Duclaux I., Kanitakis J., Chevallier M., et al. Familial autoimmune enteropathy with circulating anti-bullous pemphigoid antibodies and chronic autoimmune hepatitis. J Pediatr 1994, 125:858-862.
5. Lachaux A., Kaiserlian D., Bella C., Bouvier R. Flow cytometry characterization of epithelial cells released in the watery stools of a patient with autoimmune enteropathy. Am J Gastroenterol 1995, 90:856-857.
6. Lachaux A., Loras-Duclaux I., Bouvier R. Autoimmune enteropathy in infants. Pathological study of the disease in two familial cases. Virchows Arch 1998, 433:481-485.
7. Owen C.J., Jennings C.E., Imrie H., Lachaux A., Bridges N.A., Cheetham T.D., et al. Mutational analysis of the FOXP3 gene and evidence for genetic heterogeneity in the immune dysregulation, polyendocrinopathy, enteropathy syndrome. J Clin Endocrinol Metab 2003, 88:6034-6039.
8. Halabi-Tawil M., Ruemmele F.M., Fraitag S., Rieux-Laucat F., Neven B., Brousse N., et al. Cutaneous manifestations of immune dysregulation, polyendocrinopathy, enteropathy, X-linked (IPEX) syndrome. Br J Dermatol 2009, 160:645-651.
9. Ruemmele F.M., Moes N., de Serre N.P.-M., Rieux-Laucat F., Goulet O. Clinical and molecular aspects of autoimmune enteropathy and immune dysregulation, polyendocrinopathy autoimmune enteropathy X-linked syndrome. Curr Opin Gastroenterol 2008, 24:742-748.
10. Kobayashi I., Kubota M., Yamada M., Tanaka H., Itoh S., Sasahara Y., et al. Autoantibodies to villin occur frequently in IPEX, a severe immune dysregulation, syndrome caused by mutation of FOXP3. Clin Immunol 2011, 141:83-89.
11. Rubio-Cabezas O., Minton J.A.L., Caswell R., Shield J.P., Deiss D., Sumnik Z., et al. Clinical heterogeneity in patients with FOXP3 mutations presenting with permanent neonatal diabetes. Diabetes Care 2009, 32:111-116.
12. Tsuda M., Torgerson T.R., Selmi C., Gambineri E., Carneiro-Sampaio M., Mannurita S.C., et al. The spectrum of autoantibodies in IPEX syndrome is broad and includes anti-mitochondrial autoantibodies. J Autoimmun 2010, 35:265-268.
13. Clark L.B., Appleby M.W., Brunkow M.E., Wilkinson J.E., Ziegler S.F., Ramsdell F. Cellular and molecular characterization of the scurfy mouse mutant. J Immunol 1999, 162:2546-2554.
14. Yong P.L., Russo P., Sullivan K.E. Use of sirolimus in IPEX and IPEX-like children. J Clin Immunol 2008, 28(5):581-587.